Evolution of echocardiography in subclinical detection of cancer therapy-related cardiac dysfunction

Echocardiography
Rohit MoudgilSyed Wamique Yusuf

Abstract

Cancer therapies have resulted in increased survivorship in oncological patients. However, the benefits have been marred by the development of premature cardiovascular disease. The current definition outlines measurement of ejection fraction as a mean to diagnose cancer therapeutic-related cardiac dysfunction (CTRCD); however, up to 58% of the patients do not regain their cardiac function after the CTRCD diagnosis, despite therapeutic interventions. Therefore, there has been a growing interest in the markers for early myocardial changes (ie, changes with normal left ventricular ejection fraction [LVEF]) that may predict the development of subsequent left ventricular ejection fraction reduction or progression to heart failure. This review will highlight the use of diastolic parameters, tissue Doppler imaging (TDI), and speckle tracking echocardiogram (STE) as emerging technologies which can potentially detect cardiac dysfunction thereby stratifying patients for cardioprotective therapies. The goal of this manuscript was to highlight the concepts and discuss the current controversies surrounding these echocardiographic imaging modalities.

References

Jan 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J L SpeyerM Meyers
Jan 1, 1994·Acta Oncologica·M S EwerM K Thapar
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew SeidmanDeborah Keefe
Jun 22, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B V JensenS L Nielsen
Nov 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven E LipshultzSteven D Colan
Oct 18, 2003·Journal of Cancer Research and Clinical Oncology·S M Swain, P Vici
Jul 13, 2004·The New England Journal of Medicine·Steven E LipshultzStephen E Sallan
Jan 12, 2005·European Journal of Heart Failure·Gedske DaugaardAndreas Kjaer
Jun 9, 2005·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Sophie Tassan-ManginaPierre Nazeyrollas
Dec 13, 2006·Journal of the American College of Cardiology·Nihat KalayAli Ergin
Jul 3, 2007·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Javier GanameLuc Mertens
Aug 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Melinda L TelliAlice E Guardino
Dec 2, 2008·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Ruxandra JurcutJens-Uwe Voigt
Feb 2, 2010·Journal of the American College of Cardiology·Daniela CardinaleCarlo M Cipolla
Aug 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniela CardinaleCarlo M Cipolla
Feb 23, 2011·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Victor Mor-AviJosé Luis Zamorano
May 28, 2011·Echocardiography·Yiu-fai CheungShau-yin Ha
Jun 29, 2011·Archives of Internal Medicine·Carmel M HalleyWael A Jaber
Sep 20, 2011·European Heart Journal Cardiovascular Imaging·Hirohiko MotokiUichi Ikeda
Sep 24, 2011·Journal of the American College of Cardiology·John Gorcsan, Hidekazu Tanaka
Oct 4, 2011·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Paul W StoodleyLiza Thomas
Jun 26, 2012·International Journal of Cardiology·Mehmet G KayaYat Yin Lam
Aug 18, 2012·Asia-Pacific Journal of Clinical Oncology·Begül Yağci-KüpeliMünevver Büyükpamukçu
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G CuriglianoUNKNOWN ESMO Guidelines Working Group
Jun 12, 2013·Journal of the American College of Cardiology·Clyde W YancyUNKNOWN American Heart Association Task Force on Practice Guidelines
Jul 31, 2013·Canadian Journal of Physiology and Pharmacology·Cristian Mornoş, Lucian Petrescu
Dec 9, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carolyn D RunowiczPatricia A Ganz

❮ Previous
Next ❯

Citations

Oct 18, 2018·European Journal of Heart Failure·Dimitrios FarmakisGerasimos Filippatos
May 15, 2019·Current Opinion in Cardiology·Abdulrazzak ZarifaJuan Lopez-Mattei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.